ResearchMoz

Medtronic, Inc. (MDT) - Product Pipeline Analysis, 2014 Update

GlobalData
Published Date » 2014-07-22
No. Of Pages » 119
Summary  Medtronic, Inc. (Medtronic) is a medical technology company. It carries out the development, manufacturing and marketing of a wide range of medical devices, therapies and services used in the treatment of chronic conditions such as heart disease, spinal conditions, neurological disorders, vascular disease and diabetes. The companys operating divisions include Cardiac Rhythm Disease Management (CRDM), Coronary, Structural Heart and Endovascular , Spinal, Neuromodulation, Surgical Technologies and diabetes. Medtronic serves physicians, patients and clinicians in the US, Europe and Asia-Pacific. The company is headquartered in Minnesota, the US.   Medtronic focuses on rapid and cost-effective delivery of quality products to a diverse group of customers. The company envisages...
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 10
Medtronic, Inc. Company Snapshot 11
Medtronic, Inc. Company Overview 11
Key Information 11
Medtronic, Inc. Pipeline Products and Clinical Trials Overview 11
Medtronic, Inc. Pipeline Analysis Overview 14
Business Description 14
Key Facts 14
Medtronic, Inc. - Major Products and Services 15
Medtronic, Inc. Pipeline Products by Development Stage 18
Medtronic, Inc. Clinical Trials by Trial Status 22
Medtronic, Inc. Pipeline Products Overview 27
Activa PC+S DBS System 27
Activa PC+S DBS System Product Overview 27
Activa PC+S DBS System Clinical Trial 28
Amplify rhBMP-2 32
Amplify rhBMP-2 Product Overview 32
Amplify rhBMP-2 Clinical Trial 33
Antibiotic Eluting Bone Paste 34
Antibiotic Eluting Bone Paste Product Overview 34
Attain Performa 35
Attain Performa Product Overview 35
Attain Performa Clinical Trial 36
Cardioblate Closure Left Atrial Appendage Occlusion Device 37
Cardioblate Closure Left Atrial Appendage Occlusion Device Product Overview 37
CoreValve Delivery Catheter System With AccuTrak Stability Layer 38
CoreValve Delivery Catheter System With AccuTrak Stability Layer Product Overview 38
CoreValve EnVeo R Recapturable Delivery System 39
CoreValve EnVeo R Recapturable Delivery System Product Overview 39
CoreValve Evolut R Recapturable System 40
CoreValve Evolut R Recapturable System Product Overview 40
CoreValve Evolut R Recapturable System Clinical Trial 41
CoreValve System - VIV Procedure 42
CoreValve System - VIV Procedure Product Overview 42
Direct Aortic Delivery System - Engager Valve 43
Direct Aortic Delivery System - Engager Valve Product Overview 43
Endurant II AAA Stent Graft System 44
Endurant II AAA Stent Graft System Product Overview 44
Endurant II AAA Stent Graft System Clinical Trial 45
Engager Transcatheter Aortic Valve Implantation System 46
Engager Transcatheter Aortic Valve Implantation System Product Overview 46
Engager Transcatheter Aortic Valve Implantation System Clinical Trial 47
Enlite II Sensor 49
Enlite II Sensor Product Overview 49
Enlite II Sensor Clinical Trial 50
Evera MRI SureScan ICD 51
Evera MRI SureScan ICD Product Overview 51
GENius Multi-channel RF Generator 52
GENius Multi-channel RF Generator Product Overview 52
Heart Pacemaker 53
Heart Pacemaker Product Overview 53
IN.PACT Admiral Drug Eluting Balloon 54
IN.PACT Admiral Drug Eluting Balloon Product Overview 54
IN.PACT Admiral Drug Eluting Balloon Clinical Trial 55
IN.PACT Amphirion Paclitaxel Eluting Balloon Catheter 57
IN.PACT Amphirion Paclitaxel Eluting Balloon Catheter Product Overview 57
IN.PACT Amphirion Paclitaxel Eluting Balloon Catheter Clinical Trial 58
Infuse Bone Graft - Cervical Fusion 59
Infuse Bone Graft - Cervical Fusion Product Overview 59
Infuse Bone Graft - Posterolateral Fusions 60
Infuse Bone Graft - Posterolateral Fusions Product Overview 60
Integrated Guardian Real-Time Continuous Glucose Monitoring System 61
Integrated Guardian Real-Time Continuous Glucose Monitoring System Product Overview 61
Intercept Patient Programmer For Activa PC - Refractory Epilepsy 62
Intercept Patient Programmer For Activa PC - Refractory Epilepsy Product Overview 62
Intercept Patient Programmer For Activa PC - Refractory Epilepsy Clinical Trial 63
Micra LeadLess Pacemaker 64
Micra LeadLess Pacemaker Product Overview 64
Micra LeadLess Pacemaker Clinical Trial 65
MiniMed 640G 66
MiniMed 640G Product Overview 66
MiniMed 640G Clinical Trial 67
Multi-Array Ablation Catheter 68
Multi-Array Ablation Catheter Product Overview 68
Multi-Array Septal Catheter 69
Multi-Array Septal Catheter Product Overview 69
Native Outflow Tract Transcatheter Pulmonary Valve 70
Native Outflow Tract Transcatheter Pulmonary Valve Product Overview 70
Native Outflow Tract Transcatheter Pulmonary Valve Clinical Trial 71
NC Euphora Balloon Catheter 72
NC Euphora Balloon Catheter Product Overview 72
Next Generation TCV 73
Next Generation TCV Product Overview 73
O-arm Imaging System Next Version 74
O-arm Imaging System Next Version Product Overview 74
ONSTIM Device 75
ONSTIM Device Product Overview 75
Patch Pump 76
Patch Pump Product Overview 76
Percutaneous Transfemoral Transcatheter Mitral Heart Valve 77
Percutaneous Transfemoral Transcatheter Mitral Heart Valve Product Overview 77
Phased RF Ablation System 78
Phased RF Ablation System Product Overview 78
PNS Device 79
PNS Device Product Overview 79
PNS Device Clinical Trial 80
Portable Hemodialysis System 81
Portable Hemodialysis System Product Overview 81
Prestige LP Cervical Disc 82
Prestige LP Cervical Disc Product Overview 82
Prestige LP Cervical Disc Clinical Trial 83
PrimeADVANCED - Heart Failure 84
PrimeADVANCED - Heart Failure Product Overview 84
PrimeADVANCED - Heart Failure Clinical Trial 85
Pulmonary Vein Ablation Catheter 86
Pulmonary Vein Ablation Catheter Product Overview 86
Medtronic, Inc. - Key Competitors 102
Medtronic, Inc. - Key Employees 103
Medtronic, Inc. - Key Employee Biographies 105
Medtronic, Inc. - Locations And Subsidiaries 106
Head Office 106
Other Locations & Subsidiaries 106
Recent Developments 111
Medtronic, Inc., Recent Developments 111
Jul 02, 2014: People with Type 2 Diabetes Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily Injections 111
Jul 02, 2014: Medtronic Announces Class I Recall Of Duet Neuro Drainage And Monitoring Systems 111
Jun 25, 2014: Study Published in The New England Journal of Medicine Finds Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients Better Than Standard Care 112
Jun 19, 2014: Medtronic Increases Its Cash Dividend By Nine Percent 112
Jun 19, 2014: Medtronic Announces Preliminary Outcomes for World's Smallest Cardiac Pacemaker 113
Jun 18, 2014: Study Shows CRT-D Devices with Medtronic AdaptivCRT Associated with Reduction of Costs of Atrial Fibrillation 113
Jun 17, 2014: Medtronic Launches $17-Million Program to Improve Heart Disease, Diabetes Care for Underserved Populations 114
Jun 12, 2014: Medtronic CoreValve System Receives FDA Approval for Patients at High Risk for Surgery 115
Jun 11, 2014: Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease 116
Jun 04, 2014: Medtronic Says Special Litigation Committee Files Motion For Approval In Derivative Suit 117
Appendix 119
Methodology 119
About GlobalData 119
Contact Us 119
Disclaimer 119

List of Tables
Medtronic, Inc., Key Facts 11
Medtronic, Inc. Pipeline Products and Clinical Trials Overview 11
Medtronic, Inc. Pipeline Products by Equipment Type 12
Medtronic, Inc. Pipeline Products by Indication 13
Medtronic, Inc. Clinical Trials by Trial Status 13
Medtronic, Inc., Key Facts 14
Medtronic, Inc., Major Products and Services 15
Medtronic, Inc. Number of Pipeline Products by Development Stage 18
Medtronic, Inc. Pipeline Products Summary by Development Stage 19
Medtronic, Inc. Clinical Trials by Trial Status 22
Medtronic, Inc. Clinical Trials Summary 23
Activa PC+S DBS System - Product Status 27
Activa PC+S DBS System - Product Description 27
Activa PC+S DBS System - A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (Dbs-f) in Patients With Mild Probable Alzheimer's Disease 28
Activa PC+S DBS System - Chronic Effects of Deep Brain Stimulation on Cortical Local Field Potentials in Parkinson's Disease and Dystonia 28
Activa PC+S DBS System - Comparison of Constant Current to Constant Voltage Stimulation in Subthalamic DBS for Parkinson's Disease 28
Activa PC+S DBS System - Deep Brain Stimulation for Treatment Resistant Depression: Exploration of Local Field Potentials (LFP) with the Medtronic Activa Primary Cell + Sensing (PC+S) "Brain Radio" System 29
Activa PC+S DBS System - Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression 29
Activa PC+S DBS System - Deep Brain Stimulation of the Amygdala for Combat Post-Traumatic Stress Disorder 29
Activa PC+S DBS System - Early Versus Late Introduction of STN DBS in PD Patients With Motor Complications: A Prospective, Comparative Multicentre Clinical Study 30
Activa PC+S DBS System - Local Field Potential Correlates of Motor Behavior and Pathological Signs in Movement Disorders for Development of Closed Loop Stimulation Systems 30
Activa PC+S DBS System - Neural Signatures of Tremor, Bradykinesia and Freezing in the Subthalamic Region on Parkinson's Disease and Their Acute and Long-Term Modulation by Subthalamic Deep Brain Stimulation 30
Activa PC+S DBS System - Phase I Study of Bilateral DBS to the Nucleus Accumbens (NAcc-DBS) for Treatment Resistant Bipolar Disorder 31
Activa PC+S DBS System - Tourette Syndrome Deep Brain Stimulation: Modulation of Oscillations for the Treatment of Tourette Syndrome 31
Amplify rhBMP-2 - Product Status 32
Amplify rhBMP-2 - Product Description 32
Amplify rhBMP-2 - rhBMP-2 vs Autologous Bone Grafting For The Treatment Of Non-union Of The Docking Site In Tibial Bone Transport 33
Antibiotic Eluting Bone Paste - Product Status 34
Antibiotic Eluting Bone Paste - Product Description 34
Attain Performa - Product Status 35
Attain Performa - Product Description 35
Attain Performa - Attain Performa Quadripolar Lead Study 36
Attain Performa - Attain Success Japan Study 36
Cardioblate Closure Left Atrial Appendage Occlusion Device - Product Status 37
Cardioblate Closure Left Atrial Appendage Occlusion Device - Product Description 37
CoreValve Delivery Catheter System With AccuTrak Stability Layer - Product Status 38
CoreValve Delivery Catheter System With AccuTrak Stability Layer - Product Description 38
CoreValve EnVeo R Recapturable Delivery System - Product Status 39
CoreValve EnVeo R Recapturable Delivery System - Product Description 39
CoreValve Evolut R Recapturable System - Product Status 40
CoreValve Evolut R Recapturable System - Product Description 40
CoreValve Evolut R Recapturable System - The Medtronic CoreValve Evolut R Clinical Study 41
CoreValve System - VIV Procedure - Product Status 42
CoreValve System - VIV Procedure - Product Description 42
Direct Aortic Delivery System - Engager Valve - Product Status 43
Direct Aortic Delivery System - Engager Valve - Product Description 43
Endurant II AAA Stent Graft System - Product Status 44
Endurant II AAA Stent Graft System - Product Description 44
Endurant II AAA Stent Graft System - EVAR Treatment With the Endurant Stent Graft of Challenging Anatomy in Experienced Hands, The Real World Experience 45
Engager Transcatheter Aortic Valve Implantation System - Product Status 46
Engager Transcatheter Aortic Valve Implantation System - Product Description 46
Engager Transcatheter Aortic Valve Implantation System - Catheter-Based Transapical Implantation of the Ventor Embracer Heart Valve Prosthesis in Patients With Severe Aortic Valve Disease 47
Engager Transcatheter Aortic Valve Implantation System - Engager Direct Aortic Clinical Study: Medtronic Engager Transcatheter Aortic Valve Implantation System Via Direct Aortic Approach 47
Engager Transcatheter Aortic Valve Implantation System - Pivotal Trial for Engager Transcatheter Aortic Valve Implantation System In Patients Suffering From Severe Aortic Stenosis 47
Engager Transcatheter Aortic Valve Implantation System - The Engager ALIGN Study: To Characterize the Safety and Clinical Benefit of the Engager Transcatheter Aortic Valve Implantation System in a Real World Environment 48
Engager Transcatheter Aortic Valve Implantation System - Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial 48
Enlite II Sensor - Product Status 49
Enlite II Sensor - Product Description 49
Enlite II Sensor - A Performance Evaluation of the Enlite and Enlite 2 Glucose Sensor to Support a Full 144 Hours (6 Days) of Use in Children 50
Evera MRI SureScan ICD - Product Status 51
Evera MRI SureScan ICD - Product Description 51
GENius Multi-channel RF Generator - Product Status 52
GENius Multi-channel RF Generator - Product Description 52
Heart Pacemaker - Product Status 53
Heart Pacemaker - Product Description 53
IN.PACT Admiral Drug Eluting Balloon - Product Status 54
IN.PACT Admiral Drug Eluting Balloon - Product Description 54
IN.PACT Admiral Drug Eluting Balloon - Medtronic Reaches Major Milestone in Clinical Program for 'IN.PACT Admiral' Drug-Eluting Balloon 55
IN.PACT Admiral Drug Eluting Balloon - Prospective, Multi-center and Randomized Controlled Clinical Study to Verify Effectiveness and Safety of Drug-eluting Balloon in PTA Procedure 55
IN.PACT Admiral Drug Eluting Balloon - Randomized Trial Of IN.PACT (Paclitaxel) Admiral Drug-Eluting Balloon (DEB) Versus Standard Percutaneous Transluminal Angioplasty (PTA) For The Treatment Of Atherosclerotic Lesions In The Superficial Femoral Artery (SFA) And/Or Proximal Popliteal Artery (PPA) 55
IN.PACT Admiral Drug Eluting Balloon - Randomized Trial of IN.PACT Admiral Drug Eluting Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease 56
IN.PACT Admiral Drug Eluting Balloon - The IN.PACT Global Clinical Study for the Treatment of Comprehensive Superficial Femoral and/or Popliteal Artery Lesions Using the IN.PACT Admiral Drug-Eluting Balloon 56
Medtronic, Inc., Key Employees 103
Medtronic, Inc., Key Employee Biographies 105
Medtronic, Inc., Subsidiaries 106

List of Figures
Medtronic, Inc. Pipeline Products by Equipment Type 12
Medtronic, Inc. Pipeline Products by Development Stage 18
Medtronic, Inc. Clinical Trials by Trial Status 22

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Poland: quartz market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the quartz market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the quartz market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Poland: trailers and semi-trailers market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the trailers and semi-trailers market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the trailers and semi-trailers market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents...
Poland: market of food grinders, mixers and juice extractors
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the food grinders, mixers and juice extractors market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the food grinders, mixers and juice extractors market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Motor Co.s Shares Suffer Downfall as Lower Profit Outlook for 2014-2015 Surface
Oct 1, 2014  
Suffering from higher recall costs in its North American market and great losses in South America and Russia have made Ford motor Co. to cut-down its forecast regarding pretax profit this year to $6 billion from $7 billion to $8 billion as earlier mentioned.  Company’s CFO Bob Shanks said that company’s pretax profit in 2015 is expected to rise between $8.5 and $9.5...
Evereadys Kenya Plant to be Shut Down
Sep 30, 2014  
The largest dry-cell battery manufacturer in the region of East Africa, Eveready East Africa Ltd. intends on shutting down its one and only factory in Kenya on the 1st of October 2014. A real estate business will be started in its place. According to the Managing Director of Eveready East Africa Ltd. the plan of shutting down the plant was initiated by the board members of this company...
Sale of Apples iPhones Remains Unaffected - Supported By Consumer Feedback
Sep 29, 2014  
iPhones have been reintroduced in the global market by Apple Inc. in about 22 countries. Consumer reports and feedback basically show that due to the presence of a problem-free backing and update, these handsets are sturdy and do not bend easily. It has been observed via stress tests conducted on iPhone 6 and 6 Plus, that it requires high force and pressure to cause damage to these...
New Malware Targets Pharma Servers
Sep 29, 2014  
The electronics and communication agency Beldon has reportedly spotted a new cyber threat to the pharmaceutical industry. Called Dragonfly, the malware specifically targets intellectual property of servers in the pharmaceutical industry with the purpose of stealing information. An initial report released by ipprolifesciences.com stated the malware was targeting the energy sector....
Child’s Success Depends on Father’s Education Level: Study
Sep 24, 2014  
A father’s level of education is the strongest attribute that can determine a child’s success in academics, according to a research conducted in Britain. It also says that there is a self-reinforcing cycle of lack of achievement and poverty that is handed down from parent to child. The report was released by the Office for National Statistics and states that children are...